Form D · Other Health Care

mPharma Data, Inc

Lexington, MA · CIK 0001664913

Offering snapshot reported Jan 30, 2024 · SEC filing

Reported sold
$13.7M
Offering amount: $13.7M
Investors reported
22
Form D · investor count
Minimum accepted
$25K
Reported outside-investor minimum
First sale
Dec 26, 2023
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 30, 2024Initial$13,669,861No comparison22SEC filing
Apr 13, 2020Amendment$18,521,879$5,314,584vs Jan 31, 202017SEC filing
Jan 31, 2020Initial$13,207,295No comparison12SEC filing
Jan 10, 2019Initial$9,729,000No comparison18SEC filing
Jan 28, 2016Initial$5,000,000No comparison14SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-503914

Source: Form D, filed Jan 30, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Dufie Addo Executive
Nana Dufie Addo Executive
Sophia Baah Executive
Walter Baddoo Director
Andrew Carruthers Director
Sangu Julius Delle Director
James Nishiyama Finucane Executive
Mayer Gniwisch Director
Amir Lahat Director
Shravin Mittal Director
Gregory Rockson Director, Executive
Joanna Lee Shevelenko Director
Daniel Shoukimas Executive
Philip Sowah Director
Daniel Vasella Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
15 Fulton Road
Lexington, MA, 02420